<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>From 1998 to 2001, 5 consecutive cases of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>/TMDS entered our hospital and achieved complete remission (CR) with continuous drip infusion of low-dose <z:chebi fb="0" ids="4911">etoposide</z:chebi> and low-dose Ara-C combined with <z:chebi fb="0" ids="50729">mitoxantrone</z:chebi> (MEtA regimen) </plain></SENT>
<SENT sid="1" pm="."><plain>The ages of the 5 patients (4 males and 1 female) ranged 32 to 50 years-old, respectively </plain></SENT>
<SENT sid="2" pm="."><plain>WBCs were 1,560-45,150/microl, blasts were 12-62% </plain></SENT>
<SENT sid="3" pm="."><plain>Bone marrow aspirates revealed trilineage <z:hpo ids='HP_0002863'>myelodysplasia</z:hpo> with various number of blasts </plain></SENT>
<SENT sid="4" pm="."><plain>These patients had an <z:hpo ids='HP_0011009'>acute onset</z:hpo> and no preceding <z:e sem="disease" ids="C1521860" disease_type="Disease or Syndrome" abbrv="">hematologic disorders</z:e> </plain></SENT>
<SENT sid="5" pm="."><plain>They were diagnosed M2/TMDS or M4/TMDS </plain></SENT>
<SENT sid="6" pm="."><plain>Continuous drip infusion of <z:chebi fb="0" ids="4911">etoposide</z:chebi> (50 mg/body/day) and Ara-C (30 mg/body/day) were given for 11-14 days and a bolus injection of <z:chebi fb="0" ids="50729">mitoxantrone</z:chebi> (8 mg/m2) was added for 2-3 days </plain></SENT>
<SENT sid="7" pm="."><plain>Patient 5 was given additional <z:chebi fb="75" ids="27847,53620">MIT</z:chebi> (6.7 mg/m2 on day 6) </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> cases achieved CR in 21-24 days after the end of the therapy </plain></SENT>
<SENT sid="9" pm="."><plain>Toxicities were <z:hpo ids='HP_0002018'>nausea</z:hpo>, <z:hpo ids='HP_0002013'>vomiting</z:hpo>, <z:hpo ids='HP_0010280'>stomatitis</z:hpo>, <z:hpo ids='HP_0001596'>alopecia</z:hpo> and <z:hpo ids='HP_0001945'>fever</z:hpo> due to <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> </plain></SENT>
<SENT sid="10" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> were well tolerable, however </plain></SENT>
<SENT sid="11" pm="."><plain>Two patients are alive more than 4 years without relapse </plain></SENT>
<SENT sid="12" pm="."><plain>MEtA regimen is available for <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>/TMDS </plain></SENT>
</text></document>